Gene expression in SK-Mel-28 human melanoma cells treated with the snake venom jararhagin

Toxicon

Volumn 57, Issue 1, 2011, Pages 1-8

  Klein, Anelise ^a   Capitanio, Juliana Silva ^a   Maria, Durvanei Augusto ^a   Ruiz, Itamar Romano Garcia ^a  

^a INSTITUTO BUTANTAN   (Brazil)

Author keywords

Gene expression; Jararhagin toxin; SK Mel 28 melanoma cells; Snake venom

Indexed keywords

ALPHA6 INTEGRIN; BETA3 INTEGRIN; BETA6 INTEGRIN; BETA7 INTEGRIN; CASPASE 3; CASPASE 5; CASPASE 6; CASPASE 8; CD51 ANTIGEN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2A; JARARHAGIN; PROTEIN P53; RNA; SNAKE VENOM; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IC 50; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION;

APOPTOSIS; CADHERINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL SURVIVAL; CROTALID VENOMS; DOWN-REGULATION; FIBROBLASTS; GENE EXPRESSION; HUMANS; INTEGRINS; MELANOMA; METALLOENDOPEPTIDASES; PLATELET AGGREGATION INHIBITORS; RNA, MESSENGER; SKIN NEOPLASMS; TUMOR STEM CELL ASSAY;

BOTHROPS JARARACA; MUS;

EID: 78650678670     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2010.09.001     Document Type: Article

References (22)

1. Brown M.C., Staniszewska I., Del Valle L., Tuszynski G.P., Marcinkiewicz C. Angiostatic activity of obtustatin as α1β1 integrin inhibitor in experimental melanoma growth. Int. J. Cancer 2008, 123:2195-2203.
2. Cai W., Chen X. Anti-angiogenic cancer therapy based on integrin αvβ3 antagonism. Anti-cancer Agents in Med. Chem. 2006, 6:407-428.
3. Corrêa M.C., Maria D.A., Moura-da-Silva A.M., Pizzocaro K.F., Ruiz I.R.G. Inhibition of melanoma cells tumorigenicity by the snake venom toxin jararhagin. Toxicon 2002, 40:739-748.
4. Gallagher P., Bao Y., Serrano S.M.T., Kamiguti A.S., Theakston R.D., Fox J.W. Use of microarrays for investigating the subtoxic effects of snake venoms: insights into venom-induced apoptosis in human umbilical vein endothelial cells. Toxicon 2003, 41:429-440.
5. Gallagher P., Bao Y., Serrano S.M.T., Laing G.D., Theakston R.D., Gutierrez J.M., Escalante T., Zigrino P., Moura-da-Silva A.M., Nischt R., Mauch C., Moskaluk C., Fox J.W. Role of the snake venom toxin jararhagin in proinflammatory pathogenesis: in vitro and in vivo gene expression analysis of the effects of the toxin. Arch. Biochem. Biophys. 2005, 441:1-15.
6. Gao L., Feng Y., Bowers R., Becker-Hapak M., Gardner J., Council L., Linette G., Zhao H., Cornelius L.A. Ras-associated protein-1 regulates extracellular signal-regulated kinase activation and migration in melanoma cells: two processes important to melanoma tumorigenesis and metastasis. Cancer Res. 2006, 66:7880-7888.
7. Hariharan S., Gustafson D., Holden S., McConkey D., Davis D., Morrow M., Basche M., Gore L., Zang C., O'Bryant C.L., Baron A., Gallemann D., Colevas D., Eckhardt S.G. Assessment of the biological and pharmacological effects of the αvβ3 and αvβ5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors. Ann. Oncol. 2007, 18:1400-1407.
8. Huveneers S., Truong H., Danen E.H.J. Integrins: signaling, disease, and therapy. Int. J. Radiat. Biol. 2007, 83:743-751.
9. Kamiguti A.S. Platelets as targets of snake venom metallotroteinases. Toxicon 2005, 45:1041-1049.
10. Kannengiesser C., Brookes S., del Arroyo A.G., Pham D., Bombled J., Barrois M., Mauffret O., Avril M.F., Chompret A., Lenoir G.M., Sarasin A., French Hereditary Melanoma Study Group, Peters G., Bressac-de Paillerets B. Functional, structural, and genetic evaluation of 20 CDKN2A germ line mutations identified in melanoma-prone families or patients. Hum. Mutat. 2009, 30:564-574.
11. Koh S.S., Opel M.L., Wei J.P., Yau K., Shah R., Gorre M.E., Whitman E., Shitabata P.K., Tao Y., Cochran A.J., Abrishami P., Binder S.W. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue. Mod. Pathol. 2009, 22:538-546.
12. Kuphal S., Bauer R., Bosserhoff A.K. Integrin signaling in malignant melanoma. Cancer Metastasis Rev. 2005, 24:195-222.
13. Kuphal S., Martyn A.C., Pedley J., Crowther L.M., Bonazzi V.F., Parsons P.G., Bosserhoff A.K., Hayward N.K., Boyle G.M. H-cadherin expression reduces invasion of malignant melanoma. Pigment Cell Melanoma Res. 2009, 22:296-306.
14. Maria D.A., Vassão R.C., Ruiz I.R.G. Haematopoietic effects induced in mice by the snake venom toxin jararhagin. Toxicon 2003, 42:579-585.
15. Nabors L.B., Mikkelsen T., Rosenfeld S.S., Hochberg F., Akella N.S., Fisher J.D., Cloud G.A., Zhang Y., Carson K., Wittemer S.M., Colevas A.D., Grossman S.A. Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma. J. Clin. Oncol. 2007, 25:1651-1657.
16. Paine M.J.L., Desmond H.P., Theakeston R.G.D., Crampton J.M. Purification, cloning and molecular characterization of a high molecular weight haemorragic metalloproteinase jararhagin from Bothrops jararaca venom. J. Biol. Chem. 1992, 267:22869-22876.
17. Reardon D.A., Fink K.L., Mikkelsen T., Cloughesy T.F., O'Neill A., Plotkin S., Glantz M., Ravin P., Raizer J.J., Rich K.M., Schiff D., Shapiro W.R., Burdette-Radoux S., Dropcho E.J., Wittemer S.M., Nippgen J., Picard M., Nabors L.B. Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme. J. Clin. Oncol. 2008, 26:5610-5617.
18. Reynolds A.R., Hart I.R., Watson A.R., Welti J.C., Silva R.G., Robinson S.D., Da Violante G., Gourlaouen M., Salih M., Jones M.C., Jones D.T., Saunders G., Kostourou V., Perron-Sierra F., Norman J.C., Tucker G.C., Hodivala-Dilke K.M. Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors. Nat. Med. 2009, 15:392-400.
19. Staniszewska I., Walsh E.M., Rothman V.L., Gaathon A., Tuszynski G.P., Calvete J.J., Lazarovici P., Marcinkiewicz C. Effect of VP12 and viperistatin on inhibition of collagen receptors-dependent melanoma metastasis. Cancer Biol. Ther. 2009, 8:1507-1516.
20. Swenson S., Costa F., Minea R., Sherwin R.P., Ernst W., Fujii G., Yang D., Markland F.S. Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol. Cancer Ther. 2004, 3:499-511.
21. Tanjoni I., Weinlich R., Della-Casa M.S., Clissa P.B., Saldanha-Gama R.F., de Freitas M.S., Barja-Fidalgo C., Amarante-Mendes G.P., Moura-da-Silva A.M. Jararhagin, a snake venom metalloproteinase, induces a specialized form of apoptosis (anoikis) selective to endothelial cells. Apoptosis 2005, 10:851-861.
22. Yamamoto M., Yamamoto A., Leung P.C., Yamamoto F. Gene expression analysis of an integrin family of genes by systematic multiplex reverse transcription-polymerase chain reaction. Electrophoresis 2004, 25:2201-2211.